D-Dimer assay as a non invasive test for the diagnosis of left atrial Thrombi in Indian patients with Rheumatic MS

Afr Health Sci. 2013 Sep;13(3):584-589. doi: 10.4314/ahs.v13i3.9.

Abstract

Background: Systemic embolism is a serious and sometime fatal complication of rheumatic MS.

Objective: We assessed the predictive power of D-Dimer level to predict occurrence of left atrial (LA) thrombi in patients with rheumatic mitral stenosis (MS).

Methods: D-dimer levels were analyzed for 24 patients with rheumatic MS with LA clot and 22 patients with rheumatic MS with no LA clot undergoing transeosophageal echocardiography. A level more than 4 µg/ml was taken as elevated to predict the presence of LA clot in the study groups.

Results: For a cut-off value of 4 µg/ml, sensitivity was 66.67 % and specificity 100 % for prediction of LA clot and AUC 0.710. A cut-off value of less than 1 µg/ml, sensitivity was 91.67 % and 87. 5 % negative predictive value for ruling out presence of LA clot and AUC 0.721.

Conclusion: A higher value of D-dimer can predict the possible presence of a LA clot and very low value can predict absence of clot in patients with rheumatic MS.

Keywords: D-Dimer levels; Left atrial thrombus; Rheumatic MS; Transoesophageal echocardiography.

MeSH terms

  • Adolescent
  • Adult
  • Female
  • Fibrin Fibrinogen Degradation Products / analysis*
  • Heart Atria
  • Heart Diseases / diagnosis*
  • Humans
  • India
  • Male
  • Middle Aged
  • Mitral Valve Stenosis / diagnosis*
  • Rheumatic Heart Disease / complications*
  • Thrombosis / diagnosis*
  • Young Adult

Substances

  • Fibrin Fibrinogen Degradation Products
  • fibrin fragment D